Need Help?

RNA-seq of iPSC-derived oligodendrocytes of individuals with and without t(1;11) translocation

This dataset contains high-throughput RNA-sequencing of 14 samples, each sample comprising oligodendrocytes derived from human induced pluripotent stem cells, from individuals with and without a balanced t(1;11) translocation which substantially increases risk of major mental illness. 5 samples derive from 2 control individuals, and 9 samples from 3 individuals carrying the translocation. Libraries were prepared from each total-RNA sample using the TruSeq Stranded Total RNA with Ribo-Zero kit. Libraries were then sequenced using the NextSeq 500/550 High-Output v2 (150 cycle) Kit on the NextSeq 550 platform. Raw paired-end sequencing data is stored in two FASTQ files per sample.

Request Access

Policy for t(1;11) translocation data set.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom University of Edinburgh (as fully defined below) grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: University of Edinburgh (as fully defined below) and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of mental disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): [Please add your institution’s full legal title here] that has requested access to the Data. University of Edinburgh: The University Court of the University of Edinburgh, a charitable body registered in Scotland under registration number SC005336, incorporated under the Universities (Scotland) Acts and having its main administrative offices at Old College, South Bridge, Edinburgh EH8 9YL. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data and no Data should be shared with any External Collaborator until they have signed an agreement in the same terms as the User Institution. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries (“Foreground IP”). In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). The User Institution grants a right to the University of Edinburgh to use the Foreground IP for internal research and development purposes. 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify University of Edinburgh within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify University of Edinburgh prior to any significant changes to the protocol for the Project. 14. The User Institution will notify University of Edinburgh as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. University of Edinburgh may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than University of Edinburgh. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for The University Court of the University of Edinburgh Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS Dataset reference (EGA Study ID and Dataset Details) EGA Study ID: xxx Edinburgh University Reference: CT-7277 Name of project that created the dataset The patient dataset from which the RNA sequencing study was carried out for is the ‘Family and Population Genetic Studies in Mental Illness’ (approved by the Multicentre Research Ethics Committee for Scotland; REC reference: 14/SS/0039; IRAS project ID: 147086). The RNA sequencing dataset was funded by a personal Clinical Research Training Fellowship award from the Wellcome Trust to Mandy Johnstone (Ref: 100135/Z/12/Z). The name of the project is: ‘Using human induced pluripotent stem cells (iPSC) and iPSC-derived neurons to explore cellular phenotypes associated with schizophrenia’. Names of other data producers/collaborators Professor Andrew McIntosh is a collaborator of this study. Dr Owen Dando and Professor Giles Hardingham are collaborators and have been involved the RNA sequencing analysis of this study. Specific limitations on areas of research The data from the RNA sequencing study is for the Family and Population Genetic Studies in Mental Illness. This includes the study of neurodevelopmental and neuropsychiatric disorders in these family samples. Minimum protection measures required Under the conditions of the ethics approval for the ‘Family and Population Genetics Studies in Mental Illness’ genetic sequence data can be available for other researchers in the field to use under a system of managed access that strictly protects confidentiality. Clinical details of the study participants will be held separately by the investigators. File access: Data can be held in unencrypted files on an institutional computer system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested - EGA Study (Dataset Accession Number: xxx) Edinburgh University Reference: CT-7277 Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY University of Edinburgh intend to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. University of Edinburgh anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until either the date on which University of Edinburgh publishes a paper relating to this dataset or 18 months after these data were first made available on the relevant hosting database.. In any publications produced by the User Institution based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., xxx), and acknowledge its use in a form agreed by the User Institution with University of Edinburgh.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004595 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00004230945 fastq.gz 4.1 GB
EGAF00004230946 fastq.gz 4.1 GB
EGAF00004230947 fastq.gz 4.2 GB
EGAF00004230948 fastq.gz 4.3 GB
EGAF00004230949 fastq.gz 4.4 GB
EGAF00004230950 fastq.gz 4.5 GB
EGAF00004230951 fastq.gz 4.2 GB
EGAF00004230952 fastq.gz 4.3 GB
EGAF00004230953 fastq.gz 6.3 GB
EGAF00004230954 fastq.gz 6.4 GB
EGAF00004230955 fastq.gz 4.2 GB
EGAF00004230956 fastq.gz 4.3 GB
EGAF00004230957 fastq.gz 5.3 GB
EGAF00004230958 fastq.gz 5.4 GB
EGAF00004230959 fastq.gz 5.2 GB
EGAF00004230960 fastq.gz 5.4 GB
EGAF00004230961 fastq.gz 3.6 GB
EGAF00004230962 fastq.gz 3.7 GB
EGAF00004230963 fastq.gz 4.0 GB
EGAF00004230964 fastq.gz 4.1 GB
EGAF00004230965 fastq.gz 3.5 GB
EGAF00004230966 fastq.gz 3.5 GB
EGAF00004230967 fastq.gz 5.5 GB
EGAF00004230968 fastq.gz 5.6 GB
EGAF00004230969 fastq.gz 5.1 GB
EGAF00004230970 fastq.gz 5.2 GB
EGAF00004230971 fastq.gz 4.1 GB
EGAF00004230972 fastq.gz 4.2 GB
28 Files (128.7 GB)